New Clot-Fighting strategy for kidney therapy during life support shows promise
NCT ID NCT05148026
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study tested whether adding a citrate-based anticoagulant to standard heparin can reduce clotting in the kidney replacement circuit for patients on heart-lung bypass (ECMO). 18 adults with severe lung and kidney failure were enrolled. The goal was to see if the combined approach keeps the kidney circuit working longer without increasing bleeding risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST MONZA-Rianimazione Generale
Monza, Italy, 20900, Italy
Conditions
Explore the condition pages connected to this study.